Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-14 Sale(A) | 2024-08-20 8:46 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 24,999 | $8 | $199,992 | 131,248 (Indirect) | View |
| 2024-08-14 Purchase | 2024-08-14 8:54 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 500,000 | $8 | $4,000,000 | 216,083 (Indirect) | View |
| 2024-08-14 Sale | 2024-08-14 8:54 pm | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 24,999 | $9 | $224,991 | 216,083 (Indirect) | View |
| 2024-05-23 Sale | 2024-05-28 4:31 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 30,000 | $6.3033 | $189,100 | 747,049 (Indirect) | View |
| 2024-02-27 Sale | 2024-02-29 9:54 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 144,000 | $4.6965 | $676,294 | 753,428 (Indirect) | View |
| 2024-01-17 Sale | 2024-01-19 4:30 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 58,889 | $4.2 | $247,334 | 784,013 (Indirect) | View |
| 2023-11-29 Sale | 2023-12-01 06:00 am | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 145,348 | $3.44 | $499,997 | 1,170,117 (Indirect) | View |
| 2022-11-08 Sale | 2022-11-09 9:39 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 350,000 | $4.4 | $1,540,000 | 164,137 (Indirect) | View |
| 2022-09-02 Sale | 2022-09-07 4:54 pm | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 6,445 | $5.2 | $33,514 | 1,889,456 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-04 Option Award | 2024-10-11 6:13 pm | 2023-12-13 2025-10-04 | IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Bios Equity Partners II LP BIOS Equity Partners III LP BP Directors LP Bios Equity Partners LP Cavu Management LP Cavu Advisors LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
| 2024-10-04 Disposition | 2024-10-11 6:13 pm | 2023-12-13 2025-06-13 | IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Bios Equity Partners II LP BIOS Equity Partners III LP BP Directors LP Bios Equity Partners LP Cavu Management LP Cavu Advisors LLC 10% Owner | 574,241 | $0 | 11,862,579 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 37,951 | $0 | 216,083 (Indirect) | View |
| 2024-08-12 Option Award | 2024-08-14 8:54 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 15,000 | $0 | 216,083 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 37,951 | $5.27 | 216,083 (Indirect) | View |
| 2024-08-14 Conversion | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 9,380,699 | $0 | 216,083 (Indirect) | View |
Ownership | 2024-08-12 6:30 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Clinical Opportunity Fund LP Bios Equity COF LP BP Directors LP 10% Owner | 0 | $0 | 8,835,435 (Indirect) | View |
| 2024-06-07 Option Award | 2024-06-11 9:33 pm | N/A 2034-06-07 | COGNITION THERAPEUTICS INC | CGTX | Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BP Directors LP Director 10% Owner | 8,500 | $0 | 6,023,000 (Indirect) | View |
| 2024-01-17 Exercise | 2024-01-19 4:30 pm | 2019-03-07 2024-03-07 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 79,021 | $0 | 784,013 (Indirect) | View |
| 2024-01-17 Exercise | 2024-01-19 4:30 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 79,021 | $3.13 | 784,013 (Indirect) | View |
| 2023-11-08 Option Award | 2023-11-13 09:48 am | N/A N/A | COGNITION THERAPEUTICS INC | CGTX | Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BP Directors LP Director 10% Owner | 500,095 | $1.05 | 6,012,000 (Indirect) | View |
| 2022-09-02 Exercise | 2022-09-07 4:54 pm | 2018-12-17 2028-12-16 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 32,538 | $0 | 1,889,456 (Indirect) | View |
| 2022-09-02 Exercise | 2022-09-07 4:54 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP 10% Owner | 32,538 | $1.03 | 1,889,456 (Indirect) | View |
Ownership | 2022-02-01 7:33 pm | N/A 2031-02-23 | COGNITION THERAPEUTICS INC | CGTX | BP Directors LP Affiliate of director Director | 0 | $0 | 1,145 (Indirect) | View |
| 2021-11-04 Option Award | 2021-11-08 5:23 pm | N/A 2031-11-04 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. BP Directors LP Bios Equity Partners LP Cavu Management LP BIOS Capital Management LP Cavu Advisors LLC BIOS Advisors GP LLC Fletcher Aaron G.L. Director 10% Owner | 3,200 | $0 | 1,764,346 (Indirect) | View |
Ownership | 2021-08-17 7:24 pm | N/A 2029-03-11 | IN8BIO INC. | INAB | Bios Equity Partners LP BP Directors LP 10% Owner | 0 | $0 | 23,275 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-16 6:21 pm | N/A 2030-06-14 | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP Director 10% Owner | 9,135 | $0 | 98,657 (Direct) | View |
| 2020-06-15 Conversion | 2020-06-16 6:21 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP Director 10% Owner | 2,293,804 | $0 | 98,657 (Indirect) | View |
Ownership | 2020-06-10 7:17 pm | N/A N/A | Lantern Pharma Inc. | LTRN | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC BP Directors LP Director 10% Owner | 0 | $0 | 1,968,478 (Indirect) | View |